Newly Identified Prostate Cancer Subtypes May Respond Differently to Treatment

[GeorgeGlass]

May 12, 2023 Newly Identified Prostate Cancer Subtypes May Respond Differently to Treatment

renalandurologynews.com/hom...

[swwags]

This is important info!

[cesces in reply to swwags]

Yes. Progress

[dhccpa]

Could be game changing. Or, for a physician in this field, practice changing.

[RMontana]

This is proof positive that before any treatment regime is decided on both Genomic and Germline testing should be done! Germline testing would reveal treatment regimes that are specific to the DNA make up of the patient...Genomic testing could show what treatments are specific to the cells of the tumor the same patient carries...but none of this is done unless you ask for it...if a shoe store could sell the same size shoe to all of its customers it would only stock that one size! Really easy and profitable business model, but it hell on the feet...check these podcasts out...Rick

healthunlocked.com/active-s...

healthunlocked.com/active-s...

[CurrentSEO]

So for example triplet therapy for de novo metastatic might be very helpful against cancer for one sub-type of it and taxotere can be just plain harmful to the patient in another sub-type... I agree that tumor profiling needs to be done before jumping on any kind of therapy